marijuana stocks news

Agritek Holdings, Inc. (AGTK)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Total Revenue 7   21   2   4  
Cost of Revenue 3 29 19 (1)
Gross Profit 4   (7) (17) 5  
Operating Expenses
Research Development
Selling General and Administrative 263 421 444 271
Non Recurring 193 17
Others
Total Operating Expenses
Operating Income or Loss (452) (428) (478) (266)
Income from Continuing Operations
Total Other Income/Expenses Net 7 12 (37) 95
Earnings Before Interest And Taxes (445) (416) (515) (171)
Interest Expense 315 420 29 225
Income Before Tax (760) (836) (544) (396)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (760) (836) (544) (396)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (760) (836) (544) (396)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (760) (836) (544) (396)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Jushi Holdings Inc. (JUSHF) Announces Participation at Upcoming Events in May 2021

Jushi Holdings Inc. Announces Participation at Upcoming Events in May 2021 Jushi…

$CBIS Names New CEO and President and new Scientific Advisory Board Chair and Clinical Development Consultant

Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO…

4Front Ventures Corp. (VRNOF) Launches New Live Resin, Limited-Edition Edibles and Comprehensive Concentrates Lineup

4Front Launches New Live Resin, Limited-Edition Edibles and Comprehensive Concentrates Lineup, Significantly…

Tetra Bio-Pharma Inc. (TBPMF) Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials

Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing…